Prognostic impact of anemia in patients with chronic heart failure - With special reference to clinical background: Report from the CHART-2 study

Circulation Journal

Volumn 79, Issue 9, 2015, Pages 1984-1993

  Yamauchi, Takeshi ^a   Sakata, Yasuhiko ^a   Takada, Tsuyoshi ^a   Nochioka, Kotaro ^a   Miura, Masanobu ^a   Tadaki, Soichiro ^a   Ushigome, Ryoichi ^a   Sato, Kenjiro ^a   Onose, Takeo ^a   Tsuji, Kanako ^a   Abe, Ruri ^a   Takahashi, Jun ^a   Miyata, Satoshi ^a   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anemia; Etiology; Heart failure; Left ventricular ejection fraction; Prognosis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; HEMOGLOBIN;

AGED; ANEMIA; ARTICLE; ATRIAL FIBRILLATION; BRAIN INFARCTION; CARDIOMYOPATHY; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEW YORK HEART ASSOCIATION CLASS; PROGNOSIS; PROSPECTIVE STUDY; VALVULAR HEART DISEASE; AGE; BLOOD; CHRONIC DISEASE; COMPLICATION; DISEASE FREE SURVIVAL; DRUG EFFECTS; HEART STROKE VOLUME; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; SURVIVAL RATE; VERY ELDERLY;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; AGED, 80 AND OVER; ANEMIA; CHRONIC DISEASE; DISEASE-FREE SURVIVAL; DIURETICS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE;

EID: 84940045031     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0174     Document Type: Article

References (29)

1. World Health Organization. Nutritional anaemias: Report of a WHO scientific group. WHO Tech Rep Ser 1968; 405: 3-37.
2. O'Meara E, Clayton T, McEntegart MB, McMurray JJV, Lang CC, Roger SD, et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: Results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation 2006; 113: 986- 994.
3. Anand IS, Kuskowski MA, Rector TS, Florea VG, Glazer RD, Hester A, et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: Results from Val-HeFT. Circulation 2005; 112: 1121-1127.
4. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: The anemia in chronic heart failure: Outcomes and resource utilization (ANCHOR) study. Circulation 2006; 113: 2713-2723.
5. Ezelowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes. Circulation 2003; 107: 223-225.
6. Cromie N, Lee C, Struthers AD. Anaemia in chronic heart failure: What is its frequency in the UK and its underlying causes? Heart 2002; 87: 377-378.
7. Groenveld HF, Januzzi JL, Damman K, Wijngaarden J, Hillege HL, Veldhuisen DJ, et al. Anemia and mortality in heart failure patients: A systematic review and meta-analysis. J Am Coll Cardiol 2008; 52: 818-827.
8. Silverberg D, Wexler D, Blum M, Wollman Y, Iaina A. The cardiorenal anaemia syndrome: Does it exist? Nephrol Dial Transplant 2003; 18(Suppl8): viii7-viii12.
9. Goicoechea M, Martin J, Sequera P, Quiroga JA, Ortiz A, Carreno V, et al. Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int 1998; 54: 1337-1343.
10. Westenbrink BD, Voors AA, Boer RA, Schuringa JJ, Klinkenberg T, Harst P, et al. Bone marrow dysfunction in chronic heart failure patients. Eur J Heart Fail 2010; 12: 676-684.
11. Roig E. Is anemia a marker of advanced disease or a therapeutic target in heart failure? Rev Esp Cardiol 2005; 58: 10-12.
12. Albitar S, Genin R, Chong MF, Serveaux MO, Bourgeon B. High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients. Nephrol Dial Transplant 1998; 13: 1206- 1210.
13. Felker GM, Shaw LK, Stough WG, O'Connor CM. Anemia in patients with heart failure and preserved systolic function. Am Heart J 2006; 151: 457-462.
14. Latado AL, Passos LCS, Darze ES, Lopes AA. Comparison of the effect of anemia on in-hospital mortality in patients with versus without preserved left ventricular ejection fraction. Am J Cardiol 2006; 98: 1631-1634.
15. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure. J Am Coll Cardiol 2003; 41: 1933-1939.
16. Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H; on behalf of the CHART-2 Investigators. Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan: First report from the CHART-2 Study. Circ J 2011; 75: 823-833.
17. Miura M, Sakata Y, Miyata S, Nochioka K, Takada T, Tadaki S, et al. Usefulness of combined risk stratification with heart rate and systolic blood pressure in the management of chronic heart failure: A report from the CHART-2 Study. Circ J 2013; 77: 2954-2962.
18. Miura M, Shiba N, Nochioka K, Takada T, Takahashi J, Kohno H, et al. Urinary albumin excretion in heart failure with preserved ejection fraction: An interim analysis of the CHART 2 study. Eur J Heart Fail 2012; 14: 367-376.
19. Nochioka K, Sakata Y, Takahashi J, Miyata S, Miura M, Takada T, et al. Prognostic impact of nutritional status in asymptomatic patients with cardiac diseases. Circ J 2013; 77: 2318-2326.
20. Sakata Y, Miyata S, Nochioka K, Miura M, Takada T, Tadaki S, et al. Gender differences in clinical characteristics, treatment and longterm outcome in patients with Stage C/D heart failure in Japan. Circ J 2014; 78: 428-435.
21. Gobel FL, Norstrom LA, Nelson RR, Jorgensen CR, Wang Y. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patientswith angina pectoris. Circulation 1978; 57: 549-556.
22. McKee PA, Castelli WP, McNamara PM, Kannel WB. Natural history of congestive heart failure: The Framingham Study. N Engl J Med 1971; 285: 1441-1446.
23. Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: Insights from the Framingham heart study of the national heart, lung, and blood institute. Circulation 2009; 119: 3070-3077.
24. R Core Team (2014). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/ (accessed May 22, 2015).
25. The national health and nutrition survey in Japan, 2011. http://www. mhlw.go.jp/bunya/kenkou/eiyou/h23-houkoku.html (accessed January 8, 2015).
26. Sakata Y, Shimokawa H. Epidemiology of heart failure in Asia. Circ J 2013; 77: 2209-2217.
27. Ghali JK, Anand IS, Abraham WT, Fonarow GC, Greenberg B, Krum H, et al. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation 2008; 117: 526-535.
28. Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, et al. Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med 2013; 368: 1210-1219.
29. Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric carbosymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009; 361: 2436-2448.